| Long-circulating and target-specific nanoparticles: theory to practice SM Moghimi, AC Hunter, JC Murray Pharmacological reviews 53 (2), 283-318, 2001 | 4638 | 2001 |
| Nanomedicine: current status and future prospects SM Moghimi, AC Hunter, JC Murray The FASEB journal 19 (3), 311-330, 2005 | 2621 | 2005 |
| Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties SM Moghimi, J Szebeni Progress in lipid research 42 (6), 463-478, 2003 | 1570 | 2003 |
| A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy SM Moghimi, P Symonds, JC Murray, AC Hunter, G Debska, A Szewczyk Molecular therapy 11 (6), 990-995, 2005 | 1234 | 2005 |
| The possible “proton sponge” effect of polyethylenimine (PEI) does not include change in lysosomal pH RV Benjaminsen, MA Mattebjerg, JR Henriksen, SM Moghimi, ... Molecular Therapy 21 (1), 149-157, 2013 | 773 | 2013 |
| Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective SM Moghimi, AC Hunter, TL Andresen Annual review of pharmacology and toxicology 52, 481-503, 2012 | 560 | 2012 |
| Poloxamers and poloxamines in nanoparticle engineering and experimental medicine SM Moghimi, AC Hunter Trends in biotechnology 18 (10), 412-420, 2000 | 504 | 2000 |
| Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo F Chen, G Wang, JI Griffin, B Brenneman, NK Banda, VM Holers, ... Nature nanotechnology 12 (4), 387-393, 2017 | 461 | 2017 |
| Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating SM Moghimi, CJH Porter, IS Muir, L Illum, SS Davis Biochemical and biophysical research communications 177 (2), 861-866, 1991 | 347 | 1991 |
| Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues D Brambilla, B Le Droumaguet, J Nicolas, SH Hashemi, LP Wu, ... Nanomedicine: Nanotechnology, Biology and Medicine 7 (5), 521-540, 2011 | 345 | 2011 |
| Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum SM Moghimi, IS Muir, L Illum, SS Davis, V Kolb-Bachofen Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1179 (2), 157-165, 1993 | 328 | 1993 |
| Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system–the concept of tissue specificity SM Moghimi, HM Patel Advanced drug delivery reviews 32 (1-2), 45-60, 1998 | 316 | 1998 |
| Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ... ACS nano 11 (1), 12-18, 2017 | 300 | 2017 |
| Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere− serum interface: implications for stealth nanoparticle engineering I Hamad, O Al-Hanbali, AC Hunter, KJ Rutt, TL Andresen, SM Moghimi ACS nano 4 (11), 6629-6638, 2010 | 295 | 2010 |
| Poly (ethylene glycol) s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process I Hamad, AC Hunter, J Szebeni, SM Moghimi Molecular immunology 46 (2), 225-232, 2008 | 279 | 2008 |
| Material properties in complement activation SM Moghimi, AJ Andersen, D Ahmadvand, PP Wibroe, TL Andresen, ... Advanced drug delivery reviews 63 (12), 1000-1007, 2011 | 273 | 2011 |
| Nanoparticles and innate immunity: new perspectives on host defence D Boraschi, P Italiani, R Palomba, P Decuzzi, A Duschl, B Fadeel, ... Seminars in immunology 34, 33-51, 2017 | 268 | 2017 |
| Dendrimers in medicine: therapeutic concepts and pharmaceutical challenges L Wu, M Ficker, JB Christensen, PN Trohopoulos, SM Moghimi Bioconjugate chemistry 26 (7), 1198-1211, 2015 | 241 | 2015 |
| Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response S Mizrahy, SR Raz, M Hasgaard, H Liu, N Soffer-Tsur, K Cohen, R Dvash, ... Journal of controlled release 156 (2), 231-238, 2011 | 241 | 2011 |
| Polycation cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine L Parhamifar, AK Larsen, AC Hunter, TL Andresen, SM Moghimi Soft Matter 6 (17), 4001-4009, 2010 | 240 | 2010 |
Alan Christy HunterAssociate Professor in Pharmaceutics (Drug Delivery and Nanomedicine)Verified email at lincoln.ac.uk
